Neuronal intrinsic homeostatic scaling-down of excitatory synapse has been implicated in epilepsy pathogenesis to prevent the neuronal circuits from hyperexcitability. Recent findings suggest a role for neuronal PAS domain protein 4 (Npas4), an activitydependent neuron-specific transcription factor in epileptogenesis, however, the underlying mechanism by which Npas4 regulates epilepsy remains unclear. We herein propose that limbic seizure activity up-regulates Npas4-homer1a signaling in the hippocampus, thereby contributing to epileptogenesis in mice. The expression level of Npas4 mRNA was significantly increased after the pentylenetetrazol (PTZ) treatment. Npas4 KO mice developed kindling more rapidly than their wild-type littermates. The expression of Homer1a in the hippocampus increased after seizure activity. Npas4 increased Homer1a promoter activity in COS7 cells. The PTZ-stimulated induction of Homer1a was attenuated in the hippocampus of Npas4 KO mice. The combination of fluorescence in situ hybridization and immunohistochemical analyses revealed that Homer1a mRNA co-localized with the Npas4 protein after the convulsive seizure response. PTZ reduced excitatory synaptic transmission at the associational/commissural fibers-CA3 synapses through the Npas4-mediated down-regulation of postsynaptic a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in hippocampal CA3 neurons. The adeno-associated virus (AAV)-mediated expression of Homer1a resulted in lower a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptor GluA1 subunit levels in the hippocampal plasma membrane fraction than in that from AAV-EGFP-transfected Npas4 KO mice. The development of kindling was more strongly suppressed in AAV-Homer1a-microinjected Npas4 KO mice than in AAV-EGFP-microinjected Npas4 KO mice. These results indicate that Npas4 functions as a molecular switch to initiate homeostatic scaling and the targeting of Npas4-Homer1a signaling may provide new approaches for the treatment of epilepsy.
Epilepsy is a common and refractory neurological disorder (Bell et al. 2014) . Current anti-epileptic drugs function by symptomatically suppressing seizures once they occur (Loscher et al. 2013) , and primarily enhance the threshold for seizures without a significant anti-epileptogenic effect (Galanopoulou et al. 2012) . Furthermore, approximately 20% of epileptic patients continue to have seizures even though they are receiving pharmacological treatment (Kwan et al. 2011) . The key to preventing and curing epilepsy is to elucidate the mechanisms underlying epileptogenesis.
Previous studies indicated that multiple factors, such as lipoprotein receptor-related protein 4 , sonic hedgehog (Feng et al. 2016 ), brain-derived neurotrophic factor (BDNF) (Mizoguchi et al. 2011; Liu et al. 2013; Gu et al. 2015) , and neuregulin 1 (Li et al. 2011; Tan et al. 2011 ) may be involved in epileptogenesis because they may affect the balance between excitatory and inhibitory neurons, leading to neuronal hyperexcitability and recurrent seizures (Turrigiano 2011) . However, our understanding of the cellular and molecular mechanisms responsible for epileptogenesis remains incomplete. An alternative and plausible explanation for epileptogenesis is the underlying neuronal intrinsic homeostasis during epilepsy which refers to the scaling process by which neurons regulate their excitability (O'Leary and Wyllie 2011; Staley 2015) , such as activityinduced Polo-like kinase 2 (Seeburg and Sheng 2008) and accumulation of postsynaptic density protein (PSD)-93/95 (Sun and Turrigiano 2011) . Previous studies reported that the homeostatic regulation of synaptic strength was controlled by the surface expression of the a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) (Seeburg and Sheng 2008; Turrigiano et al. 2008; Hu et al. 2010; Sun and Turrigiano 2011) . Synaptic AMPAR accumulation in rat cultured cortical neurons was rapidly increased or decreased within 4 h following bath application of voltage-gated sodium channel blocker tetrodotoxin or GABA A receptor antagonist bicucullin, respectively, and the synaptic scaling was maintained for up to 24 h (Ibata et al. 2008) , suggesting that transcriptional control is involved in synaptic scaling.
Neuronal PAS domain protein 4 (Npas4), a neuron-specific transcriptional factor, is critical for the activity-dependent regulation of GABAergic synapse development in vitro through affecting the expression of BDNF (Lin et al. 2008) . The expression of Npas4 is rapidly activated by excitatory synaptic activity and turns on a program of gene expression that triggers the formation and/or maintenance of inhibitory synapses on excitatory neurons (Spiegel et al. 2014) . In the regulation and maintenance of normal brain functioning, the induction of Npas4 appears to directly control activitydependent gene expression, and regulates long-lasting brain functions such as memory formation, adaptation, and synaptic plasticity (Lin et al. 2008; Yun et al. 2010; Ramamoorthi et al. 2011; Sim et al. 2013; Sun and Lin 2016; Ye et al. 2016) .
In this study, we showed that activation of the Npas4 signaling pathway after convulsive seizures plays a crucial role in intrinsic homeostatic scaling during epileptogenesis using an animal model of epilepsy, pentylenetetrazol (PTZ)-induced kindling. Furthermore, we found that Npas4 controlled the homeostatic scaling capacity of hippocampal neurons through the introduction of Homer1a, which regulates the surface expression of the AMPAR GluA1 subunit. Our results provide a molecular link between excessive neuronal hyperexcitability and the regulation of homeostatic scaling for controlling epilepsy.
Materials and methods

Animals
Eight-week-old male C57BL/6 mice (RRID:IMSR_JAX:000664) were purchased from Japan SLC (Hamamatsu, Japan). Npas4 KO mice (RRID:MGI:3828102) on a C57BL/6 genetic background were kindly provided by Dr Michael E. Greenberg (Harvard Medical School, Boston, MA, USA) and has been previously described (Lin et al. 2008) . Mice were housed in a density of five mice per cage (28 cm length 9 17 cm width 913 cm high) under standard conditions (23 AE 1°C, 50 AE 5% humidity) with a 12-h light/dark cycle. Food and water were available ad libitum. This study was approved by the Institutional Animal Care and Use Committee of Nagoya University (approved number 29201). This study was not pre-registered. Animals were handled in accordance with the guidelines established by the Institutional Animal Care and Use Committee of Nagoya University. The male mice used in this study were 8-16 weeks old and 22-29 g body weight unless otherwise indicated. We excluded three mice because of abnormal growth (e.g., low body weight less than 20 g at the age of 8 weeks old) in this study. We measured body weight gain in each mouse before the PTZ or saline treatment to minimize animals' suffering during experiments. Time-line of each experimental schedule was shown in each figure and described in each result. When neurochemical experiments were carried out, mice were decapitated under deep anesthesia with tribromoethanol (200 mg/kg, i.p.) or a combination anesthetic agent (i.p.) containing 0.15 mg/kg medetomidine, 2 mg/kg midazolam, and 2.5 mg/kg butorphanol to reduce animal pain.
PTZ-induced seizure model and seizure scoring PTZ (Sigma, St. Louis, MO, USA) was dissolved in sterile saline. Wild-type and Npas4 KO mice were randomly assigned into saline or PTZ groups by simple or permuted block method using a completely randomized digital table created in Microsoft Excel (Redmond, DC, USA). Observers were blinded to the grouping and experimental design during data collection and analysis. Behavioral experiment was carried out during 10:00-17:00. Mice were administered 45 mg/kg (i.p.) for the acute seizure model, and 25 mg/kg every 48 h for the kindling model. Mice were immediately placed in a chamber (32 cm length 9 21 cm width 913 cm high) and seizure levels were scored for 20 min. Mice showing more than three consecutive stage 4 seizure levels were defined as kindled mice. Behavioral responses to PTZ were scored according to previous studies (Ferraro et al. 1999) : stage 0, no response; stage 1, ear and facial twitching; stage 2, convulsive waves through the body; stage 3, myoclonic jerks; stage 4, clonic-tonic convulsions, turnover in the side position; stage 5, generalized clonic-tonic epileptics, loss of postural control; stage 6, death.
RNA extraction and real-time RT-PCR Hippocampal tissues were quickly dissected out on ice and total RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany). Total RNA was reverse transcribed using the PrimeScript RT Reagent Kit (Takara Bio, Kusatsu, Japan). Level of Npas4 mRNA were determined after reverse transcription by real-time PCR using an ABI PRISM 7300 real-time PCR system (Thermo Fisher Scientific, Yokohama, Japan). We also assessed cFos mRNA expression to monitor neuronal excitation (Erdtmann-Vourliotis et al. 1998) . The primers used were as follows: Npas4 forward, TCAACAGAAG GCGCAAACAC; Npas4 reverse, TGACAGGTCCTTCACCGTGA; cFos forward, AAGTAGTGCAGCCCGGAGTA; cFos reverse, CCAGTCAAGAGCATCAGCAA; Homer1a forward, GAAGTCG CAGGAGAAGATG; Homer1a reverse TGATTGCTGAATTG AATGTGTACC; Homer1c forward, ACACCCGATGTGACACAG AACT; Homer1c reverse, TCAACCTCCCAGTGGTTGCT; Gapdh forward, CAATGTGTCCGTCGTGGATCT; Gapdh reverse GTCCTC AGTGTAGCCCAAGATG.
In situ hybridization
In situ hybridization was performed using the DIG RNA Labeling Kit and DIG Nucleic Acid Detection Kit (Roche, Mannheim, Germany) as described previously (Jiang et al. 2004) . Briefly, the PCR product from mouse Npas4 (NM_153553, sequence 945-1903 bp) was inserted into the pSPT18 vector. DIG-labeled antisense or sense RNA probes were prepared from linearized plasmids using an SP6 or T7 RNA polymerase in vitro transcription kit (Roche). Frozen mouse brain sections (10 lm) were fixed in 4% paraformaldehyde (PFA), digested with Proteinase K (5 lg/mL), acetylated, and then hybridized with DIG-labeled riboprobes at 50°C overnight. DIG-labeled RNA hybrids were reacted with an AP-conjugated anti-DIG antibody (Roche, RRID:AB_514497) at 4°C overnight. Sections were washed in malate buffer (100 mM maleic acid, 150 mM NaCl) and then in AP buffer (100 mM NaCl, 100 mM Tris-HCl, pH 9.5, 50 mM MgCl 2 , 1% Tween-20). Tissue sections were treated with NBT/BCIP (Roche) mixture at 26-28°C in the dark for color development.
Fluorescence in situ hybridization (FISH) was performed as previously (Jiang et al. 2004) . The PCR product from mouse Homer1a (NM_011982, sequence 1-167 bp) was inserted into the pSPT 18 vector (Roche). Probes were prepared from linearized plasmids using an SP6 or T7 RNA polymerase in vitro transcription kit (Roche). Slices were incubated with an AP-conjugated anti-DIG antibody at 4°C overnight. Signals were visualized by an incubation with an Alexa546 anti-sheep IgG antibody (Invitrogen, Carlsbad, CA, USA, RRID:AB_1500708) at 26-28°C for 2 h. Regarding the combination of FISH and immunohistochemistry, hybridized sections were incubated with an AP-conjugated anti-DIG and anti-Npas4 antibody (provided by Dr Greenberg, RRID: AB_2687869) at 4°C overnight. Signals were visualized by an incubation with Alexa546 anti-sheep IgG and Alexa488 anti-rabbit IgG (Invitrogen, RRID:AB_141708) at 26-28°C for 2 h. Images were acquired with a Tie-A1 confocal microscope (Nikon, Sendai, Japan).
Immunohistochemistry
Mice were injected with tribromoethanol (200 mg/kg, i.p.) to lead rapid and deep anesthesia, and transcardially perfused with isotonic 0.1 M phosphate buffer (pH 7.4) followed by isotonic 4% PFA. The brain was post-fixed in 4% PFA at 4°C overnight, and then cryoprotected in 20-30% sucrose in 0.1 M phosphate buffer. Briefly, sections (20 lm) were fixed with 4% PFA and washed with 0.3% Triton X-100/phosphate-buffered saline (PBS). They were incubated for 1 h in blocking serum (5% normal donkey serum in 0.2% Triton-9 100/PBS) and at 4°C for 24 h in the presence of the primary antibody (anti-Npas4; anti-Homer1a, Santa Cruz, Dallas, TX, USA, RRID:AB_675651; anti-neuronal nuclei, sigma, RRID:AB_10711153; anti-glial fibrillary acidic protein, Sigma, RRID:AB_477010; anti-GFP, MBL, Nagoya, Japan, RRID: AB_591816). Sections were washed with PBS, and incubated with species-matched secondary antibodies (Alexa 488-conjugated antirabbit IgG; Alexa 488-conjugated anti-goat IgG, Invitrogen, RRID: AB_2534102; Alexa 546-conjugated anti-mouse IgG, Invitrogen, RRID:AB_2534012; Alexa 546-conjugated anti-goat IgG, Invitrogen, RRID:AB_142628) at 26-28°C for 1 h. Sections were imaged on the A1 confocal microscope (Nikon). The entire image of a coronal brain section was observed with a fluorescence microscope (BZ-9000, Keyence, Osaka, Japan).
Immunoblotting
Regarding the extraction of whole hippocampal lysates, tissues were homogenized in lysis buffer [20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 0.1% sodium dodecyl sulfate, 1% sodium deoxycholate, 2 mM EDTA, complete protease inhibitor cocktail (Roche), and phosSTOP phosphatase inhibitors (Roche)] at 20 000 g at 4°C for 20 min. In order to extract plasma membrane proteins, hippocampal tissues were homogenized and extracted using the Membrane Protein Extraction Kit (BioVision, Milpitas, CA, USA). Protein lysates (10 lg) were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene fluoride membrane (Immobilon-FL, Millipore, Bedford, MA, USA). Membranes were blocked with Blocking One P (Nacalai Tesque, Kyoto, Japan) or 1% skimmed milk in TBS-T (40 mM Tris, 0.3 M NaCl, and 0.1% Tween 20). The membrane was incubated with the primary antibody at 4°C overnight (AntiNpas4; Anti-cFos, Santa Cruz, RRID:AB_2106765; Anti-b-Actin, Santa Cruz, RRID:AB_630835; Anti-Homer1a; Anti-Homer1c, Santa Cruz, RRID:AB_2121001; Anti-GluA1, Millipore, RRID: AB_10680890; Anti-a1Na The luciferase assay was performed as described previously (Furukawa-Hibi et al. 2012) . COS7 cells were plated on 24-well plates at 10 000 cells/well in Dulbecco's Modified Eagle's Medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific) and antibiotics/antimycotics (Thermo Fisher Scientific) at 37°C in a humidified atmosphere with 5% CO 2 . The next day, cells were transfected with 200 ng/well of the Npas4 plasmid or empty vector, 200 ng/well of the pGL4.10 or constructed Homer1a promoter/luc, and 30 ng/well of the phRG-TK construct, which expresses renilla luciferase, using Lipofectamine 2000 (Thermo Fisher Scientific) according to the manufacturer's protocol. The renilla luciferase construct was used as a control for transfection efficiency. After 24-36 h, cell lysates were prepared and assayed for luciferase activity using the DualLuciferase Reporter Assay System (Promega). Activity tests were performed and luminescence measured using a MiniLumat luminometer (Berthold, Wildbad, Germany).
Hippocampal slice preparation and electrophysiology Hippocampal slices were prepared from the mice aged 8-12 weeks as described previously (Nakai et al. 2014) . Mice were given an intraperitoneal injection of PTZ (45 mg/kg) 24 h prior to electrophysiological recordings and were decapitated under deep anesthesia with a combination anesthetic agent (i.p.) containing 0.15 mg/kg medetomidine, 2 mg/kg midazolam, and 2.5 mg/kg butorphanol. Brains were quickly removed, and 300-lm-thick slices were cut horizontally from the hippocampus using a vibratome in ice-cold modified artificial cerebrospinal fluid (ACSF) containing 206 mM sucrose, 5 mM KCl, 8 mM MgCl 2 , 1.25 mM KH 2 PO 4 , 1 mM CaCl 2 , 26 mM NaHCO 3 , and 10 mM D-glucose. ACSF was gassed with 95% O 2 /5% CO 2 and pH was adjusted to 7.4. Slices were maintained at room temperature (26-28°C) for at least 1 h in an incubation chamber containing gassed standard ACSF containing 128 mM NaCl, 5 mM KCl, 1.3 mM MgSO 4 , 1.25 mM KH 2 PO 4 , 2.41 mM CaCl 2 , 26 mM NaHCO 3 , and 10 mM D-glucose.
A single hippocampal slice was transferred to the recording chamber in which it was superfused continuously with gassed standard ACSF at a rate of 2-2.5 mL/min at 28-30°C. A stimulating electrode (monopolar stimulation) was positioned between the hilus and the CA3 cell layer and pushed 10-40 lm into the stratum lucidum to activate the mossy fiber (MF) (Jonas et al. 1993) , or at the stratum radiatum of the CA3 region to activate associational/ commissural fibers (AC). Constant-current pulses (50 ls) were supplied by a stimulator (SEN-3301, Nihon Kohden, Tokyo, Japan) every 20 s. The intensities of test stimuli were adjusted to evoke approximately 30-50% of the maximum response. In extracellular recordings, a glass pipette filled with 2 M NaCl (2-3 MΩ) was positioned at the stratum lucidum to record field excitatory postsynaptic potentials (fEPSPs) from MF-CA3 synapses or the stratum radiatum to record fEPSPs from AC-CA3 synapses. The stability of the baseline was established by delivering test stimuli for 20-30 min before recordings. Responses from MF-CA3 synapses were identified if the group II metabotropic glutamate receptor agonist DCG-IV (1 lM) caused a more than 80% reduction in synaptic responses. The presynaptic fiber volley (PSFV) was recorded in the presence of the AMPAR blocker NBQX (10 lM) at the end of the experiments.
In whole-cell patch clamp recordings from CA3 pyramidal neurons in hippocampal slices, a patch electrode was filled with a pipette solution containing 140 mM K gluconate, 10 mM KCl, 2 mM MgCl 2 , 0.2 mM EGTA, 10 mM HEPES, 3 mM Mg-ATP, and 0.3 mM Na-GTP (pH 7.2), with 6-8 MΩ of resistance. CA3 pyramidal neurons were imaged with IR-DIC optics (BX51WI with 20 9 water immersion objective lens, OLYMPUS, Tokyo, Japan). Holding potentials were compensated for by the junction potential between the pipette solution and external solution. AMPARmediated miniature excitatory postsynaptic currents (mEPSCs) were recorded in the voltage-clamp mode at a membrane potential of À70 mV, and in the presence of tetrodotoxin (0.5 lM) and GABA A receptor antagonist picrotoxin (50 lM). Access resistance was monitored continuously during the experiment, and data obtained were discarded if access resistance fluctuated by more than 20%. Signals were amplified and filtered at 5 kHz with an amplifier (Axopatch 200B, Axon Instruments, Sunnyvale, CA, USA). Data acquisition and analyses were performed using pCLAMP 9.0 software (Axon Instruments).
Adeno-associated virus (AAV) preparation and injection
In order to construct an adeno-associated virus (AAV) vector, mouse Homer1a and Homer1c cDNA sequences were cloned into the multi cloning site of the pAAV-CAGGS-EGFP-P2A-multi cloning site plasmid as previously described (Nagai et al. 2016) . AAV vectors were prepared and tittered as described previously (Sooksawate et al. 2013) . Briefly, plasmids for the AAV vector, pHelper (Cell BioLabs, San Diego, CA, USA), and pAAV-DJ (Cell BioLabs) were transfected into HEK293 cells. After a 3-d incubation, cells were collected and purified. The titers of AAV were estimated by qPCR. Mice were anesthetized with tribromoethanol (250 mg/kg, i.p.) and positioned in a stereotaxic frame (David Kopf, Tujunga, CA, USA). The AAV virus (0.5 lL, 1.0 9 10 11 genome copies/mL) was injected into the hippocampus through a glass microinjection capillary tube at a rate of 0.1 lL/min (0.5 lL/site, six sites). The anteroposterior, mediolateral, and dorsoventral coordinates relative to the bregma were as follows (in mm): À2.0, AE1.8, À2.2; À2.0, AE1.8, À1.7; À2.8, AE3.0, À3.0.
Statistical analysis
Researchers were blinded to the group allocation in all analyses. We could not reliably assess assumptions of how well normality and equal variances fit the data because the sample sizes were small. Sample size was not pre-determined by formal power analysis statistical methods. No samples or data were excluded from the analysis. The sample number for each experiment is stated in the figures. Data analysis was performed using CS Analyzer Software (Atto Instruments), pCLAMP 9.0 software (Axon Instruments), and IBM SPSS Statistics 24 (IBM, Tokyo, Japan). All data are expressed as means AE SEM. A one-way, two-way, or three-way analysis of variance (ANOVA) was used, followed by Tukey's test when the F ratios were significant (p < 0.05). Significant differences between two groups were assessed using the Student's t-test.
Results
Homeostatic control of kindling epileptogenesis by Npas4
Repeated treatments with a subconvulsive dosage of PTZ, a GABA A receptor antagonist, is known to induce kindling, which is a commonly preferred animal model used to study epilepsy (Morimoto et al. 2004; Dhir 2012 ). C57BL/6 mice were intraperitoneally (i.p.) administered different dosages of PTZ to induce convulsive seizures. We monitored mouse behaviors for 20 min after the PTZ injection, and scored the seizure level of mice (Fig. S1a) . Although a low dose of PTZ (25 mg/kg) had a negligible effect on the seizure score, a high dose of PTZ (45 mg/kg) induced a seizure characterized by tonic convulsions, jumping, and/or running (Fig. S1b) . Therefore, C57BL/6 mice were repeatedly administered the subconvulsive dose of PTZ (25 mg/kg) every 48 h to achieve the fully kindled state (Fig. 1a) . A total of 16 injections of PTZ were required for the development of kindling, whereas no marked change in the seizure score was observed with repeated saline injections and a repeated saline plus single treatment with PTZ at the last injection (injections, F(15, 270) = 12.71, p < 0.01; PTZ treatment, F(2, 18) = 149.70, p < 0.01; interaction, F(30, 270) = 10.13, p < 0.01; two-way ANOVA; Fig. 1b ).
We assessed cFos mRNA expression, as a measure of neuronal excitation, in the hippocampus of mice 1 h after the last treatment with PTZ (Fig. 1c) . cFos mRNA levels were higher in repeated PTZ-treated kindled mice than in salinetreated control or single PTZ-treated mice (F(2, 7) = 38.6, p < 0.01; one-way ANOVA; Fig. 1d ). The expression level of Npas4 mRNA was also significantly higher after the repeated PTZ treatment than in saline-treated or single PTZ-treated mice (F(2, 7) = 38.6, p < 0.01; one-way ANOVA; Fig. 1d) . A single treatment with PTZ had no effect on Npas4 mRNA levels (Fig. 1d) . These results indicate that Npas4, as well as cFos, is induced in the hippocampus of kindled mice in an activity-dependent manner.
In order to investigate whether Npas4 participates in the sensitivity of convulsions and/or epileptogenesis, wild-type and Npas4 knockout (Npas4 KO) mice were monitored for PTZ-induced convulsive seizures and kindling. PTZ-induced convulsive seizures were observed in wild-type and Npase4 KO mice, and the scores of Npas4 KO mice were similar to those of wild-type mice (Fig. S1 ). When the time course for the development of PTZ-induced kindling was compared between wild-type and Npas4 KO mice, Npas4 KO mice developed kindling more rapidly than their wild-type littermates (injection, F(8, 96) = 18.12, p < 0.01; genotype, F(1, 12) = 36.00, p < 0.01; PTZ treatment, F(1, 12) = 286.29, p < 0.01; genotype9PTZ treatment interaction, F(1, 12) = 30.35, p < 0.01; genotype9injection interaction, F(8, 96) = 3.19, p < 0.01; PTZ treatment9injection interaction, F(8, 96) = 12.50, p < 0.01; genotype9PTZ treatment9in-jection interaction, F(8, 96) = 0.94, p = 0.49; three-way ANOVA with repeated measures; Fig. 1e ). Consistent with behavioral observations, the expression level of cFos mRNA in the hippocampus of repeated PTZ-treated Npas4 KO mice was significantly higher than that in wild-type mice after 9 PTZ injections (genotype, F(1, 12) = 34.38, p < 0.01; PTZ treatment, F(1, 12) = 140.6, p < 0.01; interaction, F(1, 12) = 0.01, p = 0.93; two-way ANOVA; Fig. 1f) , which was similar to the level detected in fully kindled wild-type animals (Fig. 1d) . These results suggest that Npas4 serves as a homeostatic factor in epileptogenesis.
Spatiotemporal expression of Npas4 after convulsive seizures In order to clarify the mechanisms by which Npas4 regulates the development of kindling, we investigated the temporal dynamics of Npas4 and cFos expression in the hippocampus of wild-type mice after convulsive seizures induced by a single injection of PTZ (45 mg/kg, Fig. 2a ). The expression of Npas4 and cFos mRNA was significantly increased in the hippocampus 0.5 and 1 h after the PTZ treatment, and returned to the basal level within 2 h (Npas4 mRNA, F(6, 21) = 21.97, p < 0.01; cFos mRNA F(6, 21) = 86.72, p < 0.01; one-way ANOVA; Fig. 2b and S2 ). Npas4 mRNA expression was the most prominent in the entire hippocampal CA subregions and dentate gyrus 1 h after the PTZ treatment (Fig. 2c) ; these areas are often associated with epileptic activity in humans and animal models of limbic epilepsy (Cavus et al. 2008; Gelinas et al. 2016) . Npas4 mRNA was virtually undetectable in the hippocampus of Npas4 KO mice after the saline or PTZ injection (Fig. 2c) . Immunoblotting analyses revealed that Npas4 and cFos protein levels were increased in the hippocampus 2 h after the PTZ treatment, and then returned to basal levels within 4 h (Npas4, F(5, 18) = 10.59, p < 0.01; cFos, F(5, 18) = 50.31, p < 0.01; one-way ANOVA; Fig. 2d ). The Npas4 protein was detected in the CA subregions and dentate gyrus after the PTZ treatment (Fig. 2e) .
PTZ-induced convulsive seizures promote Homer1a expression in the hippocampus
We examined Npas4 target genes that may serve as homeostatic factors in the epileptogenesis of PTZ-induced kindling. Based on previous chromatin immunoprecipitation sequencing screens and microarray studies on Npas4 target genes (Lin et al. 2008; Yoshihara et al. 2014) , we focused on Homer1a. Homer1a is induced by an epileptic stimulus (Cavarsan et al. 2012) and mediates the homeostatic scalingdown of excitatory synapses (Hu et al. 2010; Diering et al. 2017) . In order to establish whether convulsive seizures affect Homer1a expression, we characterized Homer1a mRNA expression in response to the PTZ treatment (45 mg/kg, Fig. 3a) . The expression of Homer1a mRNA in the hippocampus increased 2 and 4 h after seizure activity, and returned to basal levels within 8 h (F(5, 18) = 120.2, p < 0.01; one-way ANOVA; Fig. 3b ). The expression of Homer1a mRNA after the PTZ treatment was the most prominent in the hippocampal CA subregions and dentate gyrus (Fig. 3c) . Homer1a protein levels also increased in the hippocampus, and peaked 4 h after the PTZ treatment (F(5, 18) = 26.44, p < 0.01; one-way ANOVA; Fig. 3d) . However, the expression of Homer1c, a constitutive and longer isoform of Homer1, was constant, even after the PTZ treatment (Fig. S3) . Double-labeling immunohistochemistry revealed that Homer1a-positive cells co-localized with anti-neuronal nuclei-positive neurons, but not glial fibrillary acidic proteinpositive astrocytes, in the CA3 subregion of the hippocampus after the PTZ treatment (Fig. 3e) , indicating that the seizureinduced up-regulation of Homer1a predominantly occurs in neurons in the hippocampus.
Npas4 mediates PTZ-induced Homer1a expression in the hippocampus
A previous study demonstrated that Npas4 binds to a critical CGTG core element in the promoter of its target genes (Ooe et al. 2004 ). Since we identified four potential regulatory elements of Npas4 in the Homer1a promoter region, the corresponding genomic fragments (761 bp) of the promoter region were cloned into a luciferase reporter plasmid. COS7 cells were co-transfected with luciferase reporter plasmids including the Homer1a promoter with or without the Npas4 plasmid. Promoter activity was measured 24-36 h after transfection (Fig. 4a) . Compared with control cells, Npas4 co-transfected cells showed increased relative luciferase activity of more than 400% of the corresponding control cells (Homer1a promoter, F(1, 42) = 91.8, p < 0.01; Npas4, F(1, 42) = 43.84, p < 0.01; interaction, F(1, 42) = 43.23, p < 0.01; two-way ANOVA; Fig. 4b ). We subsequently attempted to identify certain functional elements in the promoter that may be activated by Npas4. Any one of four putative Npas4 response elements or all of them in the Homer1a promoter were replaced by GAGGG sequences (Fig. 4c) . The mutation of Npas4 response element #3, #4, or #1-4 significantly decreased Homer1a promoter activity, whereas the other two mutants (#1 and #2 mutant) had negligible effects (F(5, 65) = 52.77, p < 0.01; one-way ANOVA; Fig. 4c ). These results suggest that the proximal region around the core promoter of Homer1a contains two positive regulatory Npas4 response elements that contribute to the induction of Homer1a.
The present results strongly suggest that Homer1a acts as a downstream target gene in Npas4 signaling in response to convulsive seizures and kindling. In order to obtain further evidence in support of this hypothesis and confirm the cellular mechanisms underlying this effect, we employed Npas4 KO mice treated with PTZ (Fig. 4d) . The PTZ-stimulated induction of Homer1a mRNA and protein was attenuated in the hippocampus of Npas4 KO mice Fig. 4e and f) . The combination of FISH and immunohistochemical analyses revealed that Homer1a mRNA co-localized with the Npas4 protein 2 h after the convulsive seizure response (Fig. 4g) . The PTZ treatment increased cFos mRNA and protein expression in the hippocampus of Npas4 KO mice as well as wild-type mice ( Fig. S4a and S4b). Homer1c mRNA and protein levels in the hippocampus were similar between Npas4 KO and wild-type mice with or without the PTZ treatment ( Fig. S4c and S4d) . These results indicate that Npas4 promotes Homer1a expression in the hippocampus after convulsive seizures without affecting neuronal responses to PTZ or the constitutive expression of a longer form of Homer1c.
Npas4 adapts homeostatic scaling through surface AMPAR expression after convulsive seizure responses Synaptic scaling, a form of neural plasticity, maintains the fundamental properties of neuronal homeostasis after hyperor hypoexcitation of the network (Ibata et al. 2008; Turrigiano et al. 2008) . We analyzed AMPAR GluA1 subunit levels in the plasma membrane fraction extracted from the hippocampus of PTZ-treated mice (Fig. 5a ). Surface AMPAR GluA1 subunit levels significantly decreased 24 h after the PTZ treatment and this reduction was maintained at least up to 48 h later (F(3, 12) = 16.77, p < 0.01; one-way ANOVA; Fig. 5b ). The PTZ treatment had no effect on total AMPAR GluA1 subunit levels (Fig. S5a) . We then investigated whether Npas4 is involved in the down-regulation of surface AMPAR GluA1 expression after seizure activity. Npas4 KO mice were treated with PTZ, and the surface membrane protein was extracted from the hippocampus 24 h after the treatment. Reductions in AMPAR GluA1 subunit levels in the membrane fraction after the PTZ treatment were attenuated in Npas4 KO mice (genotype, F(1, 20) = 30.43, p < 0.01; PTZ treatment, F(1, 20) = 75.82, p < 0.01; interaction, F(1, 20) = 5.11, p < 0.01; two-way ANOVA; Fig. 5c ), while total AMPAR GluA1 levels were similar between Npas4 KO and wild-type mice (Fig. S5b) . Furthermore, a significant difference was observed in normalized surface GluA1 levels after the PTZ treatment between wild-type and Npas4 KO mice. These results suggest that Npas4 controls the surface expression of AMPARs in the hippocampus after convulsive seizure responses.
Npas4 reduces excitatory synaptic transmission in the hippocampus after convulsive seizure responses To clarify the physiological significance of reductions in the surface expression of AMPARs in the hippocampus after convulsive seizures, we examined the strength of evoked synaptic transmission at MF-CA3 synapses and AC-CA3 synapses in wild-type and Npas4 KO mice with or without an injection of PTZ (45 mg/kg, Fig. 5a ). PTZ significantly reduced the fEPSP/PSFV ratio at AC-CA3 synapses in wildtype mice, whereas it had no effect on that in Npas4 KO mice (genotype, F(1, 29) = 10.64, p < 0.01; PTZ treatment, F(1, 29) = 6.16, p < 0.01; interaction, F(1, 29) = 20.41, p < 0.01; two-way ANOVA; Fig. 5d ). Furthermore, a significant difference was observed in the fEPSC/PSFV ratio after the PTZ treatment between wild-type and Npas4 KO mice. On the other hand, the fEPSP/PSFV ratio at MF-CA3 synapses was not altered by PTZ in wild-type or Npas4 KO mice (Fig. S5c) , suggesting that convulsive seizure responses affect synaptic transmission evoked at AC-CA3 synapses rather than at MF-CA3 synapses.
To examine whether PTZ modulates the probability of glutamate release from MF and AC, we measured mEPSCs in hippocampal CA3 neurons from wild-type and Npas4 KO mice. PTZ significantly reduced the average amplitude of mEPSCs in wild-type mice, but not in Npas4 KO mice (genotype, F(1, 19) = 4.90, p < 0.01; PTZ treatment, F(1, 19) = 1.66, p = 0.21; genotype9PTZ interaction, F(1, 19) = 16.11, p < 0.01; two-way ANOVA; Fig. 5e ). (n = 8)(n = 8)(n = 8)(n = 9) (n = 6)(n = 6)(n = 5)(n = 6) (n = 6)(n = 6)(n = 5)(n = 6) Furthermore, a significant difference in the average amplitude of mEPSCs was evident between wild-type and Npas4 KO mice after the PTZ treatment. On the other hand, the frequency of their generation was slightly increased by PTZ in wild-type and Npas4 KO mice (Fig S5d) .
To predominantly observe synaptic inputs from AC-CA3 synapses, we measured mEPSCs in the presence of the group II metabotropic glutamate receptor agonist DCG-IV, which selectively suppresses synaptic transmission at MF-CA3 synapses, but not at AC-CA3 synapses (Kamiya et al. 1996) . The frequency of mEPSCs was decreased by DCG-IV in all groups, presumably because of the inhibition of synaptic inputs from MF (Fig. S5d) . However, the significant difference observed in the average amplitude of mEPSCs after the PTZ treatment between wild-type and Npas4 KO mice was not affected by the presence or absence of DCG-IV (genotype, F(1, 38) = 11.67, p < 0.01; PTZ treatment, F(1, 38) = 8.17, p < 0.01; DCG-IV treatment, F (1, 38) = 0.99, p = 0.32; genotype9PTZ interaction, F(1, 38) = 39.30, p < 0.01; PTZ treatment9DCG-IV treatment interaction, F(1, 38) = 1.03, p = 0.32; genotype9PTZ treatment9DCG-IV treatment interaction, F(1, 38) = 0.28, p = 0.60; three-way ANOVA; Fig. 5e ). Collectively, these results suggest that PTZ reduces excitatory synaptic transmission at AC-CA3 synapses through the Npas4-mediated down-regulation of postsynaptic AMPARs in hippocampal CA3 neurons.
Npas4 controls homeostatic scaling during kindling development through Homer1a
In order to investigate whether the expression of Homer1a in the hippocampus rescues the accelerated development of PTZ-induced kindling in Npas4 KO mice, we bilaterally microinjected AAV, which promotes the expression of Homer1a, into the hippocampus of Npas4 KO mice ( Fig. 6a and b) . Immunohistochemistry revealed the exclusive expression of the Homer1a protein and no gross abnormalities in the hippocampus of AAV-Homer1a-microinjected mice (Fig. 6c) . The AAV-mediated expression of Homer1a resulted in lower AMPAR GluA1 subunit levels in the hippocampal plasma membrane fraction than in that from AAV-EGFP-transfected Npas4 KO mice (F(2, 9) = 8.058, p < 0.01; one-way ANOVA; Fig. 6d ), whereas it had no effect on total GluA1 subunit levels (Fig. S6) . We also monitored kindling development induced by a subconvulsive dose of PTZ (Fig. 6a) . The development of kindling was more strongly suppressed in AAVHomer1a-microinjeted Npas4 KO mice than in AAV-EGFP-microinjected Npas4 KO mice, whereas the seizure threshold was not affected after the first injection (AAV treatment, F(2, 10) = 10.45, p < 0.01; PTZ treatment, F(9, 90) = 71.22, p < 0.01; interaction, F(18, 90) = 1.57, p < 0.01; two-way ANOVA; Fig. 6e ). No significant difference was observed between AAV-Homer1c and AAV-EGFP-microinjected Npas4 KO mice ( Fig. 6d and  e) . These results indicate that Homer1a, but not Homer1c is required for Npas4-mediated homeostatic scaling during kindling development.
Discussion
The main result of this study is that Npas4 functions as an intrinsic modulator of seizure activity and epileptogenesis. This conclusion is supported by several results. We demonstrated that Npas4 is selectively up-regulated in the hippocampus in response to seizure activity induced by convulsive doses of PTZ or PTZ-induced kindling. A defect in the Npas4 gene facilitated the development of kindling. Furthermore, the loss of Npas4 impaired homeostatic scaling in the hippocampus with the down-regulation of surface AMPARs expression. In addition, the expression of Homer1a in the hippocampus of Npas4 KO mice rescued the disturbance in homeostatic scaling during kindling development. Collectively, the present results suggest that Npas4 controls neuronal homeostatic scaling during epileptogenesis through the induction of Homer1a as negative feedback machinery for the management of epilepsy.
Seizure activity evoked by diverse stimuli, such as structural damage, electrical stimuli, or chemical agents, triggers a signaling cascade that culminates in the expression of many genes including the immediate-early response gene Npas4 (Renier et al. 2016) . A previous study demonstrated that Npas4 signaling was up-regulated by neuronal excitability (Lin et al. 2008) . We showed that Npas4 was upregulated within 2 h of seizure activity in a single PTZinduced convulsive seizure model and repeated PTZ-induced kindling model. Treatment with PTZ has been shown to increase the release of glutamate by blocking GABA A receptors (Feng et al. 2005) . The expression of Npas4 is induced by Ca 2+ influx through voltage-gated channels, but not by increased cAMP concentrations or neurotrophic factors (Lin et al. 2008; Speckmann et al. 2016) . Therefore, Npas4 may be immediately induced in response to excitatory glutamatergic inputs after seizure responses.
Bdnf is one of the major target genes for Npas4 (Lin et al. 2008) . Cumulative evidence in recent years has highlighted the importance of BDNF and its signaling through the TrkB receptor in limbic epileptogenesis (Liu et al. 2013; Gu et al. 2015) . Our previous findings also demonstrated that BDNF expression was increased in the hippocampus in response to PTZ-induced kindling (Mizoguchi et al. 2011) . Epileptic conditions have been reported to increase the expression level of BDNF (Ernfors et al. 1991; Altar et al. 2004) . Furthermore, Bdnf heterozygous KO mice showed a marked reduction in the rate of kindling development (Kokaia et al. 1995) , while the infusion of BDNF into the rat hippocampus induced seizures (Scharfman et al. 2002) . Accordingly, we assumed that the development of PTZ-induced kindling occurred later or was weaker in Npas4 KO mice than in wildtype mice. However, Npas4 KO mice exhibited the accelerated development of PTZ-induced kindling, suggesting that Npas4 serves as a critical negative feedback factor to suppress the development of kindling. This negative feedback factor induced by Npas4 appears to have a greater impact on epileptogenesis than BDNF. These results are consistent with the brain's capacity for activity-dependent self-regulation, and suggest a novel intrinsic mechanism by which Npas4 adapts to and represses epileptic conditions (Ibata et al. 2008; O'Leary and Wyllie 2011) .
It has been demonstrated that Npas4 interacts with Homer1a gene in the mouse brain using chromatin immunoprecipitation sequencing analysis (Yoshihara et al. 2014) .
The promoter region of Homer1 contains several response elements for transcription factors including CRE-binding protein and Npas4. PTZ has been shown to decrease the phosphorylation levels of CRE-binding protein in the hippocampus of rats (Ullah et al. 2015) . In this study, we demonstrated that Npas4 increased Homer1a promoter activity in COS7 cells through Npas4 response elements. The PTZ treatment increased Homer1a mRNA and protein levels, and the induction of Homer1a was markedly attenuated in the hippocampus of Npas4 KO mice. Furthermore, co-localization of the Npas4 protein and Homer1a mRNA was observed in the hippocampus of PTZ-treated mice. These results indicate that Homer1a is one of the Npas4 target genes.
Homer1 belongs to a family of scaffolding proteins that localize at the PSD (Hayashi et al. 2009 ). Homer1 proteins are primarily classified into two isoforms. The long form of Homer1 (Homer1L) including Homer1c is constitutively expressed and consists of an N-terminal EVH1-binding domain followed by a coiled-coil domain that mediates dimerization with other Homer proteins. The EVH1-binding domain of Homer1 binds to Shank, group I metabotropic glutamate receptors (mGluR1/5), inositol-1,4,5-triphosphate (IP3) receptors, and ryanodine receptors (Shiraishi-Yamaguchi and Furuichi 2007) . Homer1a is the short form of Homer1 and is induced in an activity-dependent manner. Homer1a has the ability to interact with PSD target proteins, but cannot self-assemble because it lacks the C-terminal coiled-coil domain. Therefore, Homer1a is regarded as a dominant negative regulator that interferes with PSD complexes (Shiraishi-Yamaguchi and Furuichi 2007) . Homeostatic adaptation is associated with alterations in postsynaptic AMPAR expression at excitatory synapses which is through removal and dephosphorylating of synaptic AMPARs and this process is mediated by alterations in the signaling of protein kinase A and mGluR1/5 (Cavarsan et al. 2012; Diering et al. 2017) . It has been suggested to occur in a manner that maintains relative synaptic strength by effectively scaling all synapses . Many studies have provided strong evidence that AMPARs undergo rapid recycling in the postsynaptic compartment. Hu et al. (2010) demonstrated that Homer1a expression reduced the tyrosine phosphorylation of GluA2 through agonist-independent mGluR1/5 activity, and its tyrosine phosphorylation regulated GluA2 trafficking followed by a reduction in AMPAR-mediated synaptic strength, thereby playing an indispensable role in the expression of certain forms of synaptic plasticity. The expression of Homer1a has been shown to decrease the postsynaptic protein Shank in spines, and inhibit postsynaptic AMPAR and N-methyl-D-aspartate receptor currents in the hippocampal neurons (Sala et al. 2003) , while the homeostatic scaling of AMPARs is impaired in the primary cultured cortical neurons of Homer1a KO mice (Hu et al. 2010) . In this study, PTZ treatment decreased the surface expression of the AMPAR GluA1 subunit and AMPAR-mediated mEPSCs at AC-CA3 synapses in the hippocampus of wild-type mice 24 h after the treatment. The PTZ-induced down-regulation of AMPAR GluA1 was attenuated in Npas4 KO mice. Npas4 KO mice did not show the PTZ-induced reductions in AMPAR-mediated mEPSCs at AC-CA3 synapses. Collectively, these results suggest that neuronal hyperexcitability induced by PTZ treatment leads to a down-regulation of postsynaptic AMPARs in the hippocampal CA3 neurons of wild-type mice to induce compensatory changes in excitatory synaptic transmission within 24 h, whereas Npas4 KO mice lacked the capability to downregulate postsynaptic AMPARs after PTZ treatment.
The application of AAV-Homer1a to the hippocampus of Npas4 KO mice promoted the down-regulation of surface AMPAR GluA1 subunit expression and normalized the facilitated development of kindling induced by PTZ. Transgenic mice that express Homer1a showed the attenuation of electrical stimulation-induced kindling (Potschka et al. 2002) . The expression of Homer1a reduces synaptic AMPARmediated currents recorded from pyramidal neurons in organotypic cultures of hippocampal slices (Sala et al. 2003) . Previous studies demonstrated that Homer1a regulated the homeostatic scaling of AMPARs through mGluR1/5 (Hu et al. 2010; Diering et al. 2017) . Homer1a in PSD binds to mGluR1/ 5 and activates signaling to promote AMPAR endocytosis (Hu et al. 2010) . Thus, homeostatic scaling by Npas4-Homer1a signaling may interact with the mGluR1/5-HomerL-IP3R complex.
In conclusion, our results highlighted a previously unknown mechanism of Npas4 that contributes to epileptogenesis and is dependent on Home1a transcription in vivo. The Npas4-dependent expression of Homer1a may be required for maintaining excitation of the neuronal network through the adaptation of homeostatic scaling by AMPAR endocytosis after seizure activity. Based on the results of this study, we propose that Npas4 functions as a molecular switch to initiate homeostatic scaling and the targeting of Npas4-Homer1a signaling may provide new approaches for the treatment of epilepsy.
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